⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SILO News
Silo Pharma, Inc. Common Stock
Form 8-K
sec.gov
SILO
Form 8-K
sec.gov
SILO
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
globenewswire.com
SILO
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
globenewswire.com
SILO
Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents
globenewswire.com
SILO
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
globenewswire.com
SILO
Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy
globenewswire.com
SILO
Form 8-K
sec.gov
SILO
Form 8-K
sec.gov
SILO
Silo Pharma Announces Share Buyback Program
globenewswire.com
SILO